Last updated: April 22, 2024
Sponsor: University Hospital, Geneva
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anxiety Disorders
Treatment
Sleep Hygiene + Odor
Sleep Hygiene
Imagery Rescripting (IR)
Clinical Study ID
NCT06335784
2023-00456
Ages 18-45 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age between 18 and 45 years
- Insomnia disorder according to the International Classification of Diseases 3 (ICSD-3)
- ISI > 10
- PSQI > 5
- No other current treatment for Insomnia
Exclusion
Exclusion Criteria:
- patients with another psychiatric disorder requiring acute treatment according toDSM-5
- patients with medical (e.g. neurological disorders) or other disorders explaining thepredominant complaint of insomnia (e.g., sleep apneas with ODI>15/h, restless legssyndrome, periodic limb movements with PLM>15, chronic pain)
- patients with significant substance use/withdrawal
- patients with heavy smoking
- known pregnancy
- patients suffering from anosmia, olfactory related issues and respiratory pathology
Study Design
Total Participants: 120
Treatment Group(s): 5
Primary Treatment: Sleep Hygiene + Odor
Phase:
Study Start date:
April 22, 2024
Estimated Completion Date:
August 31, 2027
Connect with a study center
Center for Sleep Medicine
Geneva,
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.